Zevra Therapeutics, Inc.ZVRANASDAQ

Revenue (LTM)

$106M

+350.9% YoY

Net Income (LTM)

$83M

+178.9% YoY

Free Cash Flow

$-2M

Revenue CAGR (5Y)

+51.6%

Marginsdeclining

FCF($0.0B)

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	29	10↓64.5%	27↑170.3%	24↓14.0%	106↑350.9%
Gross Profit	27	10↓62.6%	25↑146.7%	16↓33.9%	86↑430.6%
Operating Income	8	-43↓650.7%	-50↓16.5%	-87↓75.4%	-4↑95.1%
Net Income	-9	-27↓212.9%	-46↓72.0%	-106↓129.1%	83↑178.9%
EBITDA	-8	-26↓223.6%	-44↓70.6%	-76↓75.5%	-0↑99.8%
EPS Diluted	-2.11	-0.78↑63.0%	-1.30↓66.7%	-2.28↓75.4%	1.35↑159.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	112	65↓41.7%	43↓34.2%	34↓21.5%	62↑84.7%
Total Current Assets	115	93↓19.3%	87↓6.4%	86↓1.0%	223↑159.2%
Total Assets	133	115↓13.2%	172↑49.4%	178↑3.4%	285↑59.8%
Total Current Liabilities	4	12↑184.2%	74↑513.2%	34↓53.8%	39↑15.3%
Total Liabilities	6	40↑590.7%	110↑174.6%	138↑25.3%	130↓6.1%
Total Equity	127	75↓40.9%	62↓17.6%	40↓35.9%	155↑289.9%
Total Debt	2	19↑1067.1%	44↑133.1%	60↑37.8%	63↑4.8%
Net Debt	-111	-47↑57.8%	1↑101.5%	27↑3602.7%	1↓97.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	10	-19↓279.3%	-34↓79.2%	-70↓107.7%	-2↑97.7%
Capital Expenditure	-0	-0↑8.8%	-0↓218.3%	0	-1
Free Cash Flow	10	-19↓282.0%	-34↓79.9%	-70↓105.9%	-2↑96.5%
Stock-Based Comp	2	4↑76.3%	6↑38.7%	15↑150.4%	13↓15.2%
Net Change in Cash	108	-47↓143.4%	-22↑52.2%	-9↑58.7%	29↑408.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance